CPT® Code 17000 is used to report the destruction of a premalignant skin lesion (such as actinic keratosis) for the first lesion. This procedure can be performed using various destruction methods, including cryotherapy (liquid nitrogen), electrosurgery, laser therapy, or chemical agents. The goal of this procedure is to prevent the progression of premalignant lesions to malignant skin cancer.
Key Facts About CPT® 17000
Service type: Procedural dermatology
Provider type: Physicians and qualified healthcare professionals
Medical services included: Yes, destruction of a premalignant lesion
Number of lesions: First lesion (additional lesions reported separately using 17003)
Common methods: Cryotherapy, electrosurgery, laser, or chemical destruction
Common clinical indications:
- Actinic keratosis
- Solar keratosis
- Dysplastic epidermal lesions with potential for malignancy
- Preventive treatment of skin lesions in sun-exposed areas
When to Use CPT® 17000
CPT 17000 is appropriate when:
- A premalignant skin lesion is destroyed using an accepted method
- Only the first lesion is treated; additional lesions use CPT 17003
- The procedure is medically necessary to prevent progression to skin cancer
- Proper documentation of lesion location, size, and method is completed
Examples:
- Cryotherapy of a single actinic keratosis on the forearm
- Laser ablation of a solar keratosis on the scalp
- Electrosurgical destruction of a dysplastic epidermal lesion on the face
Documentation Requirements
To support CPT 17000 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication for lesion destruction
- Lesion location, size, and description
- Destruction method used (cryotherapy, electrosurgery, laser, etc.)
- Number of lesions treated (first lesion documented separately)
- Patient response and any complications
- Provider credentials and signature
Thorough documentation ensures compliance, supports reimbursement, and provides continuity of care.
Reimbursement and Coding Considerations
- CPT 17000 is billed for the first premalignant lesion treated
- Additional lesions are reported separately using CPT 17003
- Coverage is typically provided when medically necessary for premalignant skin lesions
- Documentation must support lesion type, method of destruction, and number of lesions
- Verify payer-specific guidelines for dermatology procedural reimbursement
Accurate coding and documentation help ensure proper reimbursement and reduce claim denials.
How OptiMantra Supports Premalignant Lesion Procedures
OptiMantra’s integrated EMR and practice management system streamlines documentation and billing for CPT 17000:
With OptiMantra, providers can:
- Record lesion details including location, size, and clinical indication
- Record the destruction method and patient response
- Document the number of lesions treated per session
- Link procedures to patient care plans for preventive dermatology
- Support compliant, audit-ready billing codes for lesion destruction
By centralizing procedural documentation and billing, OptiMantra helps practices improve efficiency, ensure compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
